Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of Wall Streets Top analysts upgrades, downgrades and initiations for Wednesday, as follows:
Allergan PLC (NYSE:AGN) was reiterated as Buy with a 280 price target at Argus.
Calyxt Inc. (NASDAQ:CLXT) was started as Buy and assigned a 16 price target at Jefferies, and Wells Fargo started coverage as Outperform with a 17 price target.
Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) was reiterated as Outperform and with a 34 price target at Wedbush Securities.
FirstEnergy Corp. (NYSE:FE) was raised to Outperform from In-Line at Evercore ISI.
Kala Pharmaceuticals Inc. (NASDAQ:KALA) was started as Outperform with a 46 price target at Wedbush. JPMorgan started coverage as Overweight and assigned a 35 price target. Merrill Lynch started it with a Buy rating and a $33 price objective.
Latest posts by HEFFX (see all)
- Tesla Is Hiring Someone To Defend Elon Musk And Fend Off Attacks By Twitter Trolls - January 20, 2021
- PayPal Will Continue To Profit From A Huge Increase In Volume And Accounts - January 20, 2021
- Google’s Ethical AI Division Investigating Sharing of Sensitive Documents - January 20, 2021